Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity

29 May 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Mitochondrial Function and Pathology
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34053042
DOI: 10.1007/s11356-021-14619-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severityPMID 34053042Read ↗

Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic StrategiesSemantic proximity Read ↗

Targeting Mitochondria as a Therapeutic Approach for Parkinson’s DiseaseSemantic proximity Read ↗

Mitochondrial dysfunction and possible treatments in Parkinson's disease—a reviewSemantic proximity Read ↗

Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to TherapySemantic proximity Read ↗

Expanding insights of mitochondrial dysfunction in Parkinson's diseaseSemantic proximity Read ↗

Emerging concepts of mitochondrial dysfunction in Parkinson’s disease progression: Pathogenic and therapeutic implicationsSemantic proximity Read ↗

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and OpportunitiesSemantic proximity Read ↗

Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the InterplaySemantic proximity Read ↗

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesisSemantic proximity Read ↗

The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's DiseaseSemantic proximity Read ↗

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's DiseaseSemantic proximity Read ↗

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.